Parkside Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,000
Closed -$784K 99
2023
Q4
$784K Hold
5,000
0.13% 70
2023
Q3
$779K Sell
5,000
-3,113
-38% -$514K 0.14% 67
2023
Q2
$1.34M Buy
+8,113
New +$1.31M 0.25% 54
2022
Q2
Sell
-6,533
Closed -$1.16M 120
2022
Q1
$1.16M Sell
6,533
-1,967
-23% -$335K 0.23% 62
2021
Q4
$1.45M Buy
8,500
+2,000
+31% +$327K 0.28% 58
2021
Q3
$1.05M Sell
6,500
-550
-8% -$93.8K 0.22% 63
2021
Q2
$1.24M Sell
7,050
-604
-8% -$100K 0.24% 64
2021
Q1
$1.26M Buy
7,654
+154
+2% +$24.9K 0.26% 66
2020
Q4
$1.18M Buy
+7,500
New +$1.11M 0.26% 67
2020
Q3
Sell
-3,000
Closed -$421K 96
2020
Q2
$421K Hold
3,000
0.11% 88
2020
Q1
$393K Hold
3,000
0.13% 83
2019
Q4
$437K Buy
+3,000
New +$407K 0.11% 92
2018
Q4
Sell
-180
Closed -$24K 132
2018
Q3
$24K Buy
+180
New +$23.9K 0.01% 117

Other funds holding JNJ

Parkside Investments's JNJ Position: Q1 2024 in Review

Parkside Investments sold out of Johnson & Johnson (JNJ) in Q1 2024, closing a stake of 5,000 shares — an estimated $784K sold.

Parkside Investments first reported a position in JNJ in Q3 2018 and held it in 13 quarters. The position peaked at $1.45M in Q4 2021. 3,848 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.

  • Parkside Investments reported no remaining Johnson & Johnson position as of Q1 2024 after selling out during the quarter.
  • Parkside Investments sold 5,000 Johnson & Johnson shares in Q1 2024, an estimated $784K.
  • Parkside Investments first reported a position in Johnson & Johnson in Q3 2018 and held it in 13 quarters.
  • Parkside Investments's Johnson & Johnson position peaked at $1.45M in Q4 2021.
  • 3,848 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.

Based on Parkside Investments's 13F filing for Q1 2024, filed 12 Apr 2024.